Nanologica AB (publ) (STO:NICA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.532
+0.010 (1.92%)
Apr 29, 2026, 12:40 PM CET
-49.33%
Market Cap 62.63M
Revenue (ttm) 21.13M
Net Income (ttm) -51.29M
Shares Out 119.97M
EPS (ttm) -0.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,905,189
Average Volume 6,340,278
Open 0.518
Previous Close 0.522
Day's Range 0.482 - 0.550
52-Week Range 0.330 - 2.250
Beta -0.34
RSI 48.64
Earnings Date Apr 24, 2026

About Nanologica AB

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and pu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 19
Stock Exchange Nasdaq Stockholm
Ticker Symbol NICA
Full Company Profile

Financial Performance

In 2025, Nanologica AB's revenue was 21.13 million, an increase of 45.32% compared to the previous year's 14.54 million. Losses were -51.29 million, -21.85% less than in 2024.

Financial Statements

News

There is no news available yet.